KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Applied Therapeutics Reveals Pivotal Study Data In Hereditary Neuropathy
Applied Therapeutics Inc (NASDAQ:APLT) announced sorbitol reduction data from the ongoing global Phase 3 INSPIRE trial of oral AT-007 in approximately…
NGL Energy Partners And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones closed higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
NexImmune Shares Are Ripping Today – Read Why
NexImmune Inc (NASDAQ:NEXI) stock is up premarket after the company said that new preclinical data showed that AIM ACT T cells…
TILT Reduces Outstanding Debt By 47% YOY, Makes Board Changes
TILT Holdings Inc. (OTCQX: TLLTF), (NEO:TILT) announced a series of transactions that alleviates its near-term debt maturity and further reduces the company’s non-revolving debt to $46 million, down from $86.7 million in December 2021.
LAVA Therapeutics Announced Initial Data from the Ongoing Phase 1/2a Clinical Trial of LAVA-1207 in Therapy Refractory mCRPC at the 2023 ASCO GU Symposium
- LAVA Therapeutics N.V. (Nasdaq: LVTX) today announced initial clinical data from its ongoing Phase 1/2a study of LAVA-1207 in patients with therapy refractory metastatic castration resistant prostate cancer (mCRPC).
What’s Going On With Tenon Medical Stock Today?
Tenon Medical Inc (NASDAQ: TNON) shares are trading higher Wednesday after the company announced it's seeking withdrawal of its registration statement because it no longer wishes to conduct a public offering.
Canada’s Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
Ontario-based Red Light Holland Corp. (OTCQB: TRUFF) has committed to becoming an aligned supporter and advocate with the non-profit TheraPsil.
Medical Cannabis For Autism: Zelira Receives $8.6M For FDA Clinical Trials For Treatment
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a developer of cannabinoid-based medicines, will conduct FDA Phase 2 and Phase 3 clinical trials for its HOPE-1 treatment of Autism Spectrum Disorder (ASD).